See more : Isramco Negev 2 Limited Partnership (ISRA.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Allurion Technologies Inc. (ALUR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allurion Technologies Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Haier Smart Home Co., Ltd. (HSHCY) Income Statement Analysis – Financial Results
- TaiRx, Inc. (6580.TWO) Income Statement Analysis – Financial Results
- American Pacific Rim Commerce Group (APRM) Income Statement Analysis – Financial Results
- Bosun Co., Ltd. (002282.SZ) Income Statement Analysis – Financial Results
- PLANISWARE PROMESSES (PLNW.PA) Income Statement Analysis – Financial Results
Allurion Technologies Inc. (ALUR)
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 53.47M | 64.21M | 38.24M | 0.00 |
| Cost of Revenue | 11.97M | 13.49M | 9.05M | 0.00 |
| Gross Profit | 41.50M | 50.73M | 29.19M | 0.00 |
| Gross Profit Ratio | 77.61% | 79.00% | 76.33% | 0.00% |
| Research & Development | 27.69M | 16.97M | 5.73M | 0.00 |
| General & Administrative | 46.02M | 15.37M | 8.82M | 0.00 |
| Selling & Marketing | 46.86M | 50.41M | 27.14M | 0.00 |
| SG&A | 92.88M | 65.77M | 35.96M | 4.56K |
| Other Expenses | 0.00 | -1.15M | -555.00K | -610.00 |
| Operating Expenses | 120.58M | 82.74M | 41.69M | 5.17K |
| Cost & Expenses | 132.55M | 96.22M | 50.74M | 5.17K |
| Interest Income | 0.00 | 10.66M | 49.77K | 0.00 |
| Interest Expense | 10.57M | 4.43M | 3.67M | 0.00 |
| Depreciation & Amortization | 746.00K | 895.00K | 707.00K | 206.30K |
| EBITDA | -69.03M | -32.28M | -12.35M | -5.17K |
| EBITDA Ratio | -129.11% | -48.52% | -32.29% | 0.00% |
| Operating Income | -79.08M | -32.01M | -12.50M | -5.17K |
| Operating Income Ratio | -147.90% | -49.85% | -32.69% | 0.00% |
| Total Other Income/Expenses | -1.27M | -5.59M | 115.00K | 1.00 |
| Income Before Tax | -80.34M | -37.60M | -12.39M | -5.17K |
| Income Before Tax Ratio | -150.27% | -58.56% | -32.39% | 0.00% |
| Income Tax Expense | 264.00K | 143.00K | 3.11M | -206.30K |
| Net Income | -82.30M | -37.74M | -12.39M | -5.17K |
| Net Income Ratio | -153.93% | -58.78% | -32.39% | 0.00% |
| EPS | -2.31 | -1.40 | -0.11 | 0.00 |
| EPS Diluted | -2.31 | -1.40 | -0.11 | 0.00 |
| Weighted Avg Shares Out | 35.58M | 26.92M | 107.81M | 107.81M |
| Weighted Avg Shares Out (Dil) | 35.58M | 26.92M | 107.81M | 107.81M |
Allurion Announces Launch of Offering of Common Stock and Warrants
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of its common stock, par value $0.0001 per...
Why Is Allurion (ALUR) Stock Up 140% Today?
Among the medical companies seeing a big uptick today, Allurion (NYSE: ALUR ) could be among the most closely watched on Thursday. At the time of this writing, ALUR stock is up more than 140% as investors price in some...
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average weight loss of 14% at...
Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy
Allurion (ALUR) announces positive weight loss data for its gastric balloon technology.
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Allurion Technologies, Inc. (ALUR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the...
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the American Society for Metabolic and Bariatric Surgery Annual Meeting (ASMBS) taking place in San Diego, California, June 9-13,...
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Ojas A. Buch as its new Chief Operating Officer. Effective June 3, 2024, Ojas assumed the role of Chief Operating Officer...
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the expansion of its Artificial Intelligence (AI)-powered weight loss coach, Coach Iris, to support patients prescribed GLP-1s and other anti-obesity medications and the...
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
NATICK, Mass.--(BUSINESS WIRE)--Allurion to Participate in Two Upcoming Investor Conferences in June 2024.
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the 31st European Congress on Obesity (ECO) held in Venice, Italy, on 12-15 May, 2024. Presentations include data from...
Source: https://incomestatements.info
Category: Stock Reports